Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries

OBJECTIVES: The use of the NNRTI rilpivirine in low- and middle-income countries (LMICs) is under debate. The main objective of this study was to provide further clinical insights and biochemical evidence on the usefulness of rilpivirine in LMICs. PATIENTS AND METHODS: Rilpivirine resistance was ass...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Antimicrob Chemother
Autores principales: Neogi, Ujjwal, Häggblom, Amanda, Singh, Kamalendra, Rogers, Leonard C., Rao, Shwetha D., Amogne, Wondwossen, Schülter, Eugen, Zazzi, Maurizio, Arnold, Eddy, Sarafianos, Stefan G., Sönnerborg, Anders
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2016
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4710214/
https://ncbi.nlm.nih.gov/pubmed/26518047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkv359
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares